Abstract. The reaction of divalent transition metal salts and (E)-N'-(1-(pyridin-2-yl)ethylidene)nicotinohydrazide (penh) led to the formation of [Mn(penh) 2 ] (complex 1), [Co(penh) 2 ] (complex 2), [Cu(penh) 2 ] (complex 3) and [Cd (penh) 2 ] (complex 4) complexes. The four complexes were characterized using elemental analyses, infrared spectra and single-crystal X-ray diffraction analyses. Subsequently, the complexes were used for in vitro cell level experiments to determine potential antitumor effects. The results demonstrated that the complexes exhibited a similar structure; however, they were crystallized with distinct space groups. In comparison with the uncomplexed penh ligand, all four complexes were able to markedly decrease the proliferation rate of various types of tumor cell, including the human lung cancer cell line A549, human gastric cancer cell line BGC823 and human esophageal cancer cell line Eca109, in a concentration-dependent manner. Furthermore, the complexes promoted tumor cell apoptosis, as demonstrated in the apoptosis assay, and this was confirmed using electrophoresis.
Introduction
Hydrazide-hydrazone derivatives are an important class of biologically active molecules, which have attracted the attention of medicinal chemists due to their wide-ranging pharmacological properties and their potential application as antitumor, antineoplastic, antiviral and anti-inflammatory agents (1) (2) (3) (4) (5) (6) .
In particular, aroylhydrazone complexes of transition metals are known to provide useful models for the elucidation of the underlying molecular mechanism of enzyme inhibition by hydrazine derivatives (7) and for their potential pharmacological application (8, 9) . Hydrazone derivatives of isoniazid and other hydrazides have been reported to exhibit marked antimicrobial activity (10) (11) (12) (13) (14) . Furthermore, a number of substituted hydrazone derivatives have been synthesized and evaluated for their antitumor activity, with certain promising results having been reported (15) (16) (17) .
The aim of the present study was to develop potent anticancer agents. (E)-N'-(1-(pyridin-2-yl)ethylidene) nicotinohydrazide (penh), and [Mn(penh) 2 ] (complex 1), [Co (penh) 2 ] (complex 2), [Cu(penh) 2 ] (complex 3) and [Cd(penh) 2 ] (complex 4) metal complexes were synthesized, and their cytotoxicity against human lung cancer (A549), human gastric cancer (BGC823) and human esophageal cancer (Eca109) cell lines was investigated.
Materials and methods
Materials. All starting materials were obtained commercially and used as received. The A549 human lung cancer, BGC823 human gastric cancer and Eca109 human esophageal cancer cell lines were obtained from the Cell Culture Center of the Basic Institute of Medical Sciences (Peking Union Medical College, Beijing, China). Cell culture reagents were purchased from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). An Annexin V/propidium iodide (PI) double staining kit was purchased from BD Biosciences (Franklin Lakes, NJ, USA). MTT and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Polyvinylidene fluoride (PVDF) membranes and non-fat dried milk were obtained from EMD Millipore (Billerica, MA, USA X-ray crystallography. The X-ray diffraction measurements for two complexes were performed on a SMART APEX II charge-coupled device diffractometer (Bruker Corporation) equipped with graphite monochromatized Mo-K radiation (λ=0.071073 nm) using φ-ω scan mode. Semi-empirical absorption correction was applied to the intensity data using the SADABS program (version 2.03; Bruker AXS, Inc., Billerica, MA, USA) (19) . The structures were solved and refined by full-matrix least-squares on F 2 using the SHELXTL-97 program (Bruker AXS, Inc.) (20) . All non-H atoms were refined anisotropically. All H atoms were positioned geometrically and refined using a riding model (18) . Details of the crystal parameters, data collection and refinement for complexes 1-4 are summarized in Table I .
Cytotoxic activity of the complexes. To evaluate whether or not complexes 1-4 exhibit a tumor cell killing ability, the effect of DMSO-soluble complexes 1-4 on A549 (lung cancer), BGC823 (gastric cancer) and Eca109 (esophageal cancer) human solid tumor cell lines was investigated. All three cell lines were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin and 100 µg/ml streptomycin at 37˚C in a humidified atmosphere containing 5% CO 2 . The effect of treatment with complexes 1-4 on the survival of the three human tumor cell lines was assessed using an MTT assay in distilled water. Cells were seeded in 96-well plates at 1x10 4 cells/well. Following overnight growth, the cells were cultured for 72 h in the presence of 3, 6, 9, 12, 15, 18 and 21 µmol/l complexes 1-4, with cells cultured with the corresponding uncomplexed penh ligand serving as the control group. After 72 h incubation, 20 µl MTT was added into each well and cells were incubated at 37˚C for 4 h. Culture medium was removed and 150 µl DMSO was added. The plates were agitated, prior to determination of the optical density at 570 nm using an ELISA plate reader. Images of cells were captured using an upright metallurgical microscope (BX61; magnification, x20; Olympus Corporation, Tokyo, Japan). At least three parallel experiments were performed. As complex 3 exhibited increased cytotoxic activity compared with the other complexes, particularly for the Eca109 cell line, Eca109 cells and complex 3 were selected for subsequent cell apoptosis assay and western blot analysis.
Quantification of apoptosis using Annexin V and PI double staining. Apoptotic rates were determined using flow cytometry using an Annexin V/PI apoptosis kit. Eca109 cancer cells were seeded at a density of 1x10 6 cells/well in 6-well plates, cultured overnight, and treated with 3, 6 and 9 µmol/l complex 3 for 48 h at 37˚C. After 48 h, the cells were collected by centrifugation at 200 x g for 5 min at 4˚C and washed twice with ice-cold PBS. Staining was carried out according to the manufacturer's protocol, and the cells were analyzed using a BD Acurri™ C6 flow cytometer (BD Biosciences) and analyzed using CellQuest software (version 6.0; BD Biosciences). Each experiment was carried out at least three times independently.
Western blot analysis. Eca109 cancer cells were seeded in 6-well plates overnight. Cells were treated with 4 µmol/l complex 3 for 48 h at 37˚C. Total proteins were collected and protein concentration was determined using a bicinchoninic acid protein assay. Proteins (20 µg) were separated by SDS-PAGE (12% gel), transferred onto PVDF membranes by electroblotting and probed with antibodies against p53 (1:1,000), Bax (1:1,000), Bcl-2 (1:1,000) and GAPDH (1:2,000) diluted in 5% BSA (cat. no. 10711454001; Roche Applied Science, Penzberg, Germany) and blocked using 5% dried skimmed milk overnight at 4˚C. The membranes were incubated with secondary antibody against IgG labeled with AP and detected using a Lumi-Phos™ WB enhanced chemiluminescence kit (Thermo Fisher Scientific, Inc.) at room temperature. Membranes were scanned using an HP ScanJet G4010 flatbed scanner (HP, Inc., Palo Alto, CA, USA).
Statistical analysis. Statistical analysis was performed using SAS software (version 6.12; SAS Institute, Inc., Cary, NC, USA). Measurement data are presented as the mean ± standard deviation. To compare the differences between the groups, statistical significance was determined using a one-way analysis of variance followed by Dunnett's test comparisons. P<0.05 was considered to indicate a statistically significant difference.
Results and Discussion
Crystal structures of complexes [1] [2] [3] [4] . Structures of the four complexes are presented in Fig. 1 . The complexes exhibited similar structures; however, they were crystallized in distinct space groups (Table I) . In each complex, the metal center with a (Table II) were in the normal range reported for Mn(II), Co(II), Cu(II) and Cd(II) octahedral complexes (22) . As predicted, there were no classical hydrogen bonds in any of the complexes.
IR spectra of the complexes. The IR spectra of the four complexes were similar. The ν(C=O) of the uncomplexed penh ligand were at 1,667 cm -1 ; for complexes, this peak disappeared, indicating that the amide group was involved in coordination to the metal ion through the enol form. The band at 1,580 cm -1 for the uncomplexed penh ligand was assigned to the ν(C=N) stretch, which shifted to near 1,518 cm -1 for the (3) complexes, indicating that the N atom of C=N was involved in coordination to the metal ion. The vibrations ν(N-H) disappeared in the spectra of the four complexes, indicating that the ligand was deprotonated. The novel bands near 560 cm -1 for the complexes were assigned to ν(M-O), and the weaker peaks near 470 cm -1 were assigned to ν(M-N), respectively (23, 24) , consistent with the results of X-ray diffraction analysis.
Antitumor activity of the four complexes. The four complexes were air-stable for extended periods and soluble in methanol, dimethylformamide and DMSO, slightly soluble in water, and insoluble in benzene and diethyl ether. The stability of the complexes in DMSO were determined by observing the ultraviolet (UV)-visible spectra at distinct time intervals for any potential alteration. The Cu(II) complexes investigated were prepared in DMSO and were freshly diluted in phosphate buffer (pH 7.4) for experiments. The UV-visible spectra were subsequently analyzed at various intervals. The results indicate that the UV-visible spectra remained unaltered in solution for the entire course of the experiment (72 h) and that the complexes are stable in solution.
It has been reported that arylhydrazone and its metal complexes exhibit markedly effective antitumor activities, possibly due to their NO bidentate systems (24) . In vitro cytotoxicity assays were carried out in the human A549 (human lung cancer), BGC823 (human gastric cancer) and Eca109 (human esophageal cancer) solid tumor cell lines. Following co-culture with each complex, cell proliferation was markedly inhibited. As presented in Fig. 2 , alterations in tumor cell morphology, including cell shrinkage and cell detachment, were observed. Cell survival and proliferation were determined using the MTT assay. The half-maximal inhibitory concentration (IC 50 ) were selected for subsequent cell apoptosis assay and western blot analysis.
Complex 3 induces cell apoptosis.
To determine whether the decrease in human tumor cell growth was attributable to the induction of apoptosis of cancer cells, Annexin V/PI staining and flow cytometric measurement were used to quantify the level of apoptosis. Following incubation with 3, 6 and 9 µmol/l complex 3 for 48 h, the number of apoptotic cells of Eca109 was determined. As presented in Fig. 3 , the number of apoptotic Eca109 cells was increased significantly compared with the untreated control in a dose-dependent manner (P<0.05).
Alterations in apoptotic protein expression in tumor cells.
To investigate the underlying molecular mechanism of how complexes 1-4 induce apoptosis in cancer cells, levels of proteins that serve important roles in apoptosis, including p53, Bax and Bcl-2, were determined. According to previous studies (25) (26) (27) , p53 and Bcl-2 family proteins are key regulators of the apoptotic signaling pathway. Following stimulation of internal and external factors, the expression level of protein p53 and Bax is increased in the cells, promoting apoptosis. By contrast, Bcl-2 inhibits apoptosis by preventing the release of cytochrome c from mitochondria into the cytoplasm. In the present study, following incubation with 4 µmol/l complex 3 for 48 h, the levels of p53 and Bax protein were increased, whereas the expression of Bcl-2 protein was markedly decreased (Fig. 4) . In the present study, four isostructural divalent transition metal complexes with the nicotinohydrazone (penh) ligand were isolated and characterized using elemental analysis, infrared spectroscopy and single-crystal X-ray diffraction. The results of the present study indicate that the complexes demonstrate marked cytotoxic activity against three cancer cell lines (A549 human lung cancer, BGC823 human gastric cancer and Eca109 human esophageal cancer), and the IC 50 values for the metal complexes were decreased compared with that of the nicotinohydrazone (penh) ligand. Furthermore, the complexes were also demonstrated to induce apoptosis of the cancer cells, as demonstrated using the Annexin V/PI staining and western blot analysis. Therefore, the results of the present study suggest that complexes 1-4 have potential practical application, acting as novel therapeutic reagents in the treatment of cancer. 
